FRESENIUS MEDICAL CARE NORTH AMERICA
Manufacturer adverse-event records for FRESENIUS MEDICAL CARE NORTH AMERICA come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 1997–2026 · heavy-book · elevated Death-code · balanced
Death-code intensity
FRESENIUS MEDICAL CARE NORTH AMERICA carries an elevated Death-code share
Death-coded event_type rows are 24,684 of 37,655 (65.55% · elevated tercile among 443 manufacturers). Absolute volume is heavy-book.
What the Death-code reading shows for FRESENIUS MEDICAL CARE NORTH AMERICA
The standout signal for FRESENIUS MEDICAL CARE NORTH AMERICA is Death-code intensity: 65.55% of 37,655 reports (elevated tercile), while absolute volume is heavy-book.
As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair FRESENIUS MEDICAL CARE NORTH AMERICA with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.
Reports span 20 device types, led in this extract by Death at 24,684 (65.6% of event_type total). Peak single-year volume reaches 19,619 reports across 30 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (20)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.